PriAvoid GmbH

Biotechnology
Venture roundlatest round · Oct 2025 · 12 mo ago
1backers · Helmholtz
$436kgrants · 1 grant · CORDIS
2017founded

Overview

Developing a novel class of orally available all-D-peptide therapeutics that inhibit and reverse disease-specific protein aggregation in neurodegenerative disorders.

Funding and backers

Latest round
Venture round
Oct 2025 · 12 mo ago
Grants
$436k
1 grant · CORDIS
Backers
1
Helmholtz
The money's age
Due for its next round
12 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Oct 30, 2025 Raised a round Venture round Jul 1, 2024 Won a grant $436k · CORDIS Nov 24, 2021 Raised a round Venture round Sep 18, 2017 Founded per the company register
Funding rounds
RoundDateAmountInvestorsSource
Venture round Oct 2025 — — handelsregister.de
Grant Jul 2024 $436k — CORDIS
Venture round Nov 2021 — — handelsregister.de
Registers and programsofficial lists and records that name the company
Legal entity Priavoid GmbH de_site
Registered 18 Sep 2017
Backed byfrom the funds' portfolios and accelerator catalogs
Helmholtz accelerator
Investors in similar startupsfunds that back the companies most like this one
Plug and Play
backs Relup
Playground
backs Insamo
Lux Capital
backs Cajal Tx
Type One Ventures
backs Junevity
Boston Harbor Angels
backs Astrocytes Pharmaceuticals >>
venBio Partners
backs Insamo
Similar startupsby what they do, their industry and backers
attyloid GmbHVenture round · 4 yr ago · Founded 2018
Oligomers count attyloid's sFIDA® platform technology offers a cutting-edge approach for the quantitative detection of single oligomers and…
Resolute ScienceVenture round $250k · 2 yr ago · Founded 2020
Developing a novel class of cancer therapeutics for solid tumors.
InsamoSeed $12M · 2 yr ago · Founded 2022 · 51-200 employees
Insamo is a global biotechnology company pioneering the discovery of membrane-permeable and orally available cyclic-peptides with…
JunevitySeed $10M · 20 mo ago
Junevity is a biotechnology company resetting gene networks with siRNA therapeutics to reverse disease.
Astrocytes Pharmaceuticals >>Venture round $7.5M · 5 yr ago · 1-10 employees
Harnessing the Potential of Astrocytes to Treat Brain Injuries and Diseases. Astrocyte Pharmaceuticals is developing innovative…
Relup
ReLup builds AI-powered detection infrastructure for the earlier detection of neurodegenerative disorders, starting with cognitive decline.

Financials

Total raised
$436k
Latest round
Venture - Series Unknown
Funding rounds
3
Funding rounds
Round Announced Amount
Venture - Series Unknown 2025 — Details
Grant 2024 $436k Details
Venture - Series Unknown 2021 — Details

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors1
HelmholtzVia a fund
372 portfolio companies: Marton, POMA AI GmbH, EchoSpaces GmbH and 369 more
Report a mistake

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Düsseldorf Germany
HQ
Address
40225 Düsseldorf
company site